
Thomas Barnet
Journalist
Bernard Arnault Sees Himself Leading LVMH for Another 10 Years
During the Yale CEO Summit on December 17, 2025, Bernard Arnault made it clear to Sara Eisen (CNBC) that he had no plans for an immediate handover. When questioned about his succession, the 76-year-old CEO replied, "See you in ten years."
December 18, 2025 at 03:13 am

DBV Technologies laughs, Euroapi cries
Today's stock market news is marked by a spectacular divide: biotech company DBV Technologies soars on promising clinical results, while Euroapi sinks after another warning. The defense sector is recovering amid geopolitical tensions.
December 17, 2025 at 04:36 am

Capgemini, Publicis, Mistral, Spotify… the US threatens the EU with retaliation
The Trump administration is raising the tone against the European Union, which it accuses of unfairly targeting American companies. Washington is considering restrictions on European groups in response to measures deemed "discriminatory" against tech giants.
December 17, 2025 at 04:17 am
At Ford, farewell to "all-electric" costs $19.5bn
It is reckoning time in Dearborn. The American automaker is making a drastic strategic pivot, abandoning "all-electric" in favor of hybrids, a move reflected in a colossal $19.5bn impairment. A return to pragmatism that Philippe Houchois (Jefferies) deems a necessary evil to stem losses in the electric division and secure margins, as the group raises its financial targets for 2025.
December 16, 2025 at 03:32 am
The return of Google Glass weighs on EssilorLuxottica
In 2026 Alphabet, Google's parent company, plans to launch its first generation of smart glasses integrating Gemini AI, according to Bloomberg. The project marks its return to the burgeoning augmented reality and connected devices market.
December 09, 2025 at 05:14 am

To snatch Warner from Netflix, Paramount scoffs and tries to pull Trump onto its side
Paramount Skydance has filed a hostile bid of $108.4bn to acquire Warner Bros. Discovery, citing a lack of responsiveness from Warner Bros. This move marks a new milestone in the battle for control of one of Hollywood's largest studios.
December 09, 2025 at 04:54 am

MarketScreener roundup: Poxel, Haffner, Europlasma, the Return of the Living Dead
Dilutive financings continue to ravage the stockmarket. However, as the mechanism remains legal, they keep expanding. It is therefore occasionally necessary to remind small shareholders of the havoc they cause. Here are three very current illustrations - the last one won't surprise you.
December 04, 2025 at 10:27 am
Anta, Li Ning and ASICS said to have their eyes on Puma
Amid the reshaping of the global sportswear landscape, Germany's Puma, the weak link between Adidas and Nike, is reportedly being courted by China's Anta Sports, Bloomberg has learned. A Puma takeover has been a recurring topic since the company left the Kering fold, after the group failed, like other luxury players before it, to build a bridge between luxury and mass-market fashion.
November 27, 2025 at 03:12 am

Pros expect double-digit growth in stockmarket in 2026
Strategists at major financial institutions have been looking into their crystal balls to set targets for stock indices by the end of next year. Optimism prevails, with double-digit gains anticipated in both Europe and the United States.
November 27, 2025 at 02:06 am
Tesla is falling everywhere… except on the stockmarket
Elon Musk has spent much of the year focusing on Tesla's robotics ambitions and on securing approval for his new $1 trillion pay package. In the meantime, the outlook for the carmaker's core business - selling vehicles - has darkened. And the latest European figures will do nothing to brighten the picture.
November 26, 2025 at 03:51 am
Rachel Reeves' impossible budget equation in the UK
One year after an initial fiscal shock of £40bn, Rachel Reeves is preparing new tax hikes to restore the public finances. But weak growth, doubts over the OBR's forecasts and jittery markets make the equation particularly unstable.
November 26, 2025 at 02:06 am
Novo Nordisk collapses after Alzheimer's drug fails trial
Novo Nordisk announced on Monday that the oral version of its semaglutide-based drug failed to reach its primary endpoint in advanced clinical trials assessing its efficacy against cognitive decline in patients with Alzheimer's disease.
November 24, 2025 at 06:46 am
Kering: three years to get back to the top
Kering's return to growth will require less dependence on Gucci, its flagship brand that is in difficulty, with a further reduction of its boutique network, and strengthening of internal synergies, as CEO Luca de Meo explained in an internal memo.
November 19, 2025 at 05:29 am
Mega-merger in the paint industry as Akzo Nobel and Axalta join forces
On Tuesday Akzo Nobel, the manufacturer of Dulux paint, announced its intention to acquire US-based Axalta Coating Systems. The transaction would create a group worth EUR21.56bn. Under the terms of the deal, Akzo Nobel shareholders would hold 55% of the capital of the new entity, compared with 45% for Axalta shareholders. Will this be enough to boost the stockmarket performance of both companies?
November 18, 2025 at 04:21 am
Discover our authors
- Stock Market
- Our authors
- Thomas Barnet



















